These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 4561201)
1. Tableting research and technology. Cooper J; Rees JE J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201 [No Abstract] [Full Text] [Related]
2. Disintegration of tablets. Lowenthal W J Pharm Sci; 1972 Nov; 61(11):1695-711. PubMed ID: 4569113 [No Abstract] [Full Text] [Related]
3. Drug formulation and biologic availability. Poole JW Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883 [No Abstract] [Full Text] [Related]
4. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets]. Tomassini L; Naplatanova D Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491 [No Abstract] [Full Text] [Related]
5. DEVELOPMENT OF COMPRESSED COATED POLYPILL WITH MUCOADHESIVE CORE COMPRISING OF ATORVASTATIN/CLOPIDOGREL/ASPIRIN USING COMPRESSION COATING TECHNIQUE. Shahid N; Adnan S; Farooq M; Ali S; Shabbir M; Masood Z; Waqar K; Saleem H; Gill SA; Ali T Acta Pol Pharm; 2017 Mar; 74(2):477-487. PubMed ID: 29624252 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical sciences--1968. A literature review of pharmaceutics. Bernardo PD; Russo EJ J Pharm Sci; 1969 Jul; 58(7):777-812. PubMed ID: 4898312 [No Abstract] [Full Text] [Related]
7. [Galenical possibilities and problems in protraction of drug effects (author's transl)]. Müller F Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277 [TBL] [Abstract][Full Text] [Related]
8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Kambayashi A; Blume H; Dressman J Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057 [TBL] [Abstract][Full Text] [Related]
9. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms]. Hänselmann B; Voigt R Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108 [No Abstract] [Full Text] [Related]
10. Mucoadhesive platforms for targeted delivery to the colon. Varum FJ; Veiga F; Sousa JS; Basit AW Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393 [TBL] [Abstract][Full Text] [Related]
11. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances]. Hüttenrauch R; Schmeiss U Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778 [No Abstract] [Full Text] [Related]
12. Design and evaluation of floating multi-layer coated tablets based on gas formation. Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527 [TBL] [Abstract][Full Text] [Related]
13. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting. Schmid W; Picker-Freyer KM Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the accuracy of different types of dissolution rate methods. Bolhuis GK; Lerk CF; Zuurman K Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088 [No Abstract] [Full Text] [Related]
15. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets. Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852 [TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. Hombach J; Palmberger TF; Bernkop-Schnürch A J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of drug absorption and of drug solution. Jollow DJ; Brodie BB Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653 [No Abstract] [Full Text] [Related]
18. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology. Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro availability of commercial warfarin tablets. Wagner JG; Welling PG; Lee KP; Walker JE J Pharm Sci; 1971 May; 60(5):666-77. PubMed ID: 5125762 [No Abstract] [Full Text] [Related]